Google lets healthcare providers use its AI

X-rays, MRIs and other medical images can now be read, stored and labeled using Google’s artificial intelligence tools, the search giant announced on Tuesday.

By using the tools from Google’s cloud unit, hospitals and medical companies can quickly analyze images for diagnosis or search through imaging metadata. Known as the Medical Imaging Suite, the tools can also help healthcare professionals annotate medical images automatically and build machine learning models.

“With the advancements in medical imaging technology, there’s been an increase in the size and complexity of these images,” Alissa Hsu Lynch, Google Cloud’s global lead for health tech strategy and solutions, said in an interview. “We know that AI can enable faster, more accurate diagnosis and therefore help improve productivity for healthcare workers.”

Forbes concludes, that in light of Google’s other healthcare ventures, privacy advocates may worry that the tech giant, which makes the majority of its $257 billion annual revenue from personalized ads based on user data, will use patient information for its vast advertising machine.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner